The Official Journal of Neuroscience Research Center, IUMS
OpenAlex
Works that cite this article, indexed by OpenAlex.
A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy
Research in Pharmaceutical Sciences 18(2) (2023)
Rezvan Mehrab; Hamid Sedighian; Fattah Sotoodehnejadnematalahi; Raheleh Halabian; Abbas Ali Imani Fooladi
The Cytotoxicity Effect of Recombinant Arazyme on Breast and Ovarian Cancer Cells
Eurasian Journal of Medicine and Oncology 7(4) (2023)
Roohollah Zarei Koosha; Abdolamir Ghadaksaz; Zoleikha Goleij; Ghazaleh Amjadi; Hamid Sedighian; Saber Mehdizadeh; Abbas Ali Imani Fooladi
ARA-linker-TGFαL3: a novel chimera protein to target breast cancer cells
Medical Oncology 38(8) (2021)
Abdolamir Ghadaksaz; Abbas Ali Imani Fooladi; Hamideh Mahmoodzadeh Hosseini; Taher Nejad Satari; Mohsen Amin
In silico and experimental methods for designing a potent anticancer arazyme-herceptin fusion protein in HER2-positive breast cancer
Journal of Molecular Modeling 29(5) (2023)
Farideh Rahmani; Abbas Ali Imani Fooladi; Hatef Ajoudanifar; Nazila Arbab Soleimani
miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1
Technology in Cancer Research & Treatment 19 (2020)
Kui Li; Zheng Zhou; Ju Li; Rui Hua Xiang
Cloning and expression of recombinant arazyme with anti-inflammatory and anti-breast cancer potential
Archives of Microbiology 206(7) (2024)
Zahra Yahyaee; Mona Shahpari; Seyed Sadeq Mousavi Ghahfarrokhi; Marzieh Shakoori; Saba Hashemi; Abbas Akhavan Sepahi; Mohammad Ali Faramarzi; Mohsen Amin
Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line
Research in Pharmaceutical Sciences 19(4) (2024)
Rezvan Mehrab; Hamid Sedighian; Fattah Sotoodehnejadnematalahi; Raheleh Halabian; Abbas Ali Imani Fooladi